Cardiol Therapeutics

is a biotechnology company that focuses on the research and development of drug formulations for the delivery of lipophilic drugs...
Read more
Cardiol Therapeutics President & CEO: David Elsley

President & CEO

David Elsley

CEO Approval Rating

83/100

Annual Revenue
$1.4M
Employees
14
Funding
$134.5M

Trending Companies